{
    "pmid": "41474378",
    "title": "Design, Synthesis, and Characterization of Novel, Subtype-Selective Fluorescent Antagonists Targeting the Nociceptin/Orphanin FQ Opioid Peptide Receptor.",
    "abstract": "The nociceptin/orphanin FQ opioid peptide receptor (NOPr) is a member of the opioid receptor family under investigation for the treatment of depression, Parkinson's disease, addiction, and pain. Opioid analgesics such as morphine act through Î¼-opioid receptor (MOPr) activation but cause MOPr-driven side effects that include respiratory depression, tolerance, addiction, and constipation. Bivalent NOPr/MOPr agonists have been shown to confer effective analgesia with an improved side effect profile. However, the development of new NOPr-targeting drugs is challenged by a paucity of pharmacological tools to characterize NOPr-ligands and visualize receptor expression. We report the design, synthesis, and pharmacological evaluation of the first high affinity small molecule NOPr-targeting fluorescent ligands, based on the antagonist: (2",
    "disease": "parkinson disease",
    "clean_text": "design synthesis and characterization of novel subtype selective fluorescent antagonists targeting the nociceptin orphanin fq opioid peptide receptor the nociceptin orphanin fq opioid peptide receptor nopr is a member of the opioid receptor family under investigation for the treatment of depression parkinson s disease addiction and pain opioid analgesics such as morphine act through opioid receptor mopr activation but cause mopr driven side effects that include respiratory depression tolerance addiction and constipation bivalent nopr mopr agonists have been shown to confer effective analgesia with an improved side effect profile however the development of new nopr targeting drugs is challenged by a paucity of pharmacological tools to characterize nopr ligands and visualize receptor expression we report the design synthesis and pharmacological evaluation of the first high affinity small molecule nopr targeting fluorescent ligands based on the antagonist"
}